Non Invasive Ventilation (NIV) has become a standard of care for respiratory insufficiency.  When compared to invasive ventilation, NIV is associated with lower rates of ventilator-associated pneumonia (VAP) and reduced hospital re-admissions.  

In 2012, over 1 million COPD patients were admitted to US hospitals for acute exacerbation.  Hospital re-admissions for COPD within 30 days occur in 23% of cases.  Many of these re-admissions may be preventable.  

There is strong evidence that supports noninvasive ventilation (NIV) as an effective therapy option for most COPD patients hospitalized with acute exacerbation's.  NIV has shown to be the most effective treatment option for reducing CO2 in hypercapnic COPD patients.  When initiated early, this can help reduce hospital admission rates, length of stay, and the cost of healthcare while maintaining or improving quality of life.